Dulcolax
(Bisacodyl)ApprovedSmall molecule
Boehringer IngelheimBisacodyl is used to treat constipation by stimulating bowel movements and helping you have a bowel movement. It's also used to prepare the bowel before medical procedures like colonoscopies.[2] Dulcolax is currently approved and in use across 5 indications[4].[1]
Dulcolax is one of 91 small molecule programs targeting Constipation. It is currently in Approved.
5
Indications
32
Total Trials
4
Active Trials
90
Competitors
Pipeline
Status by Indication[4][1]
Indication
Competition
Competitive Landscape
160 competitors in Autism Spectrum Disorder
#DrugCompanyPhaseTrials
1Dulcolax
Boehringer IngelheimApproved
Vraylar
AbbViePhase 3
Elavil
AstraZenecaPhase 3
Bumex
VValidus Pharmaceuticals
Phase 3
Rexulti
OtsukaPhase 3
Nuplazid
AACADIA Pharmaceuticals Inc.
Phase 3
Lithobid
SSolvay Pharmaceuticals
Phase 3
Glucophage
EMD SeronoPhase 3
Hetlioz
VVanda Pharmaceuticals
Phase 3
Circadin
NNeurim Pharmaceuticals Ltd.
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Constipation5 trials
Lubiprostone for Functional Constipation in the Under 18 Years Patients
Completed·—·Phase 3·NCT05144295·274 enrolled
Bowel Preparation4 trials
Show 1 more trial
Colonoscopy4 trials
Function2 trials
Bisacodyl Oral for Lowering Dysfunction (of Tenckhoff Catheter)
Not yet recruiting·—·Phase 4·NCT07351357·398 enrolled
14 more indications
Hospitalized Patients1 trial
Female1 trial
Colorectal1 trial
Colorectal Surgery1 trial
Autism Spectrum Disorder1 trial
Paralysis1 trial
Sources
References
- [1]
- [2]MedlinePlus Drug Information — Dulcolax drug information. U.S. National Library of Medicine, National Institutes of Health.
- [3]
- [4]Open Targets Platform — Drug–disease associations for Bisacodyl. EMBL-EBI & Wellcome Sanger Institute.
- [5]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[3]
- Highest Phase
- Approved[1]
- Company